nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer
|
Meng, Jin |
|
|
196 |
9 |
p. 764-770 |
artikel |
2 |
Adjuvante Chemotherapie in der Behandlung der Urothelkarzinome des oberen Harntraktes
|
Pape, Lea |
|
|
196 |
9 |
p. 837-840 |
artikel |
3 |
Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy
|
Lorat, Yvonne |
|
|
196 |
9 |
p. 821-833 |
artikel |
4 |
DEGRO practical guideline for partial-breast irradiation
|
Strnad, V. |
|
|
196 |
9 |
p. 749-763 |
artikel |
5 |
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy
|
Nicosia, Luca |
|
|
196 |
9 |
p. 813-820 |
artikel |
6 |
Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
|
Borm, Kai J. |
|
|
196 |
9 |
p. 771-778 |
artikel |
7 |
Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses?
|
Kirli Bolukbas, Meltem |
|
|
196 |
9 |
p. 805-812 |
artikel |
8 |
Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients
|
Münch, Stefan |
|
|
196 |
9 |
p. 787-794 |
artikel |
9 |
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
|
Paireder, Matthias |
|
|
196 |
9 |
p. 779-786 |
artikel |
10 |
Pembrolizumab in der neoadjuvanten Behandlung des frühen triple-negativen Mammakarzinoms
|
Dierks, Friederike |
|
|
196 |
9 |
p. 841-843 |
artikel |
11 |
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
|
Rades, Dirk |
|
|
196 |
9 |
p. 795-804 |
artikel |
12 |
Stellenwert der Hippocampusschonung bei therapeutischer Ganzhirnbestrahlung
|
Mayinger, Michael |
|
|
196 |
9 |
p. 844-846 |
artikel |
13 |
Superoxiddismutasemimetikum (GC4419) vs. Placebo zur Reduktion von schweren oralen Mukositiden infolge simultaner Radiochemotherapie mit Cisplatin bei Kopf-Hals-Tumoren: randomisierte, doppelblinde Phase-IIb-Studie
|
Adamietz, Irenäus A. |
|
|
196 |
9 |
p. 834-836 |
artikel |